Target
$166.64 → $167
Current stock research snapshot · 7/8/26 51 days old
ILMNIllumina
Investment conviction●●○○○2 of 5 · current snapshot
Research target$167Current stock price target
Investment thesis statusINTACTLast reviewed 7/8/26
Market cap28.55BSnapshot value · 7/8/26
Research history
See all ILMN changes ↗What changed
Target
$166.67 → $166.64
Sequencing razor-blade: sell the sequencer (NovaSeq X, now ~90% of research volume), monetize consumables forever. BIOSECURE tailwind reshoring demand to Western platforms.
BIOSECURE OMB list (~Dec 2026) reshoring Chinese sequencing share; clinical sequencing shift (MRD, early detection, companion Dx); NovaSeq X Constellation bringing WGS to existing install base.
Roche Axelios/SBX launched July 2026 — first credible high-throughput threat in years; consumables pricing pressure (volume discounts); Ultima/Element ramping; Illumina-Grail unwind distraction.
Bullish — Multiple genomics theme posts Aug 25 naming ILMN as sequencing leader; new 52w high $223.97 Aug 25. [X search Aug 2026]
Snapshot · 7/8/26🟡 Mixed · ins-$152.5M · 13F 15+/9-×0.5 · short↓0.35
Snapshot · 7/8/26